上海cmc培训生物利用和生物等效性在仿制药和新药申请中的法规要求.pptxVIP

  • 5
  • 0
  • 约1.76千字
  • 约 29页
  • 2020-02-22 发布于上海
  • 举报

上海cmc培训生物利用和生物等效性在仿制药和新药申请中的法规要求.pptx

Bioavailability and Bioequivalence Study in Generic and new Drug Applications 生物利用度和生物等效性在仿制药和新药申请中的法规要求;Agenda议程;Bioavailability – defined 生物利用度定义 ;Plasma Concentration Profile 血药浓度时间曲线;Points to Consider – BA 生物利用度PK指标 ;Approaches to Determining Bioequivalence (21 CFR 320.24) 检测生物等效性试验的各种方法 ;Single-dose, two-way crossover, fasted Single-dose, two-way crossover, fed Alternatives Single-dose, parallel, fasted Long Half-Life (wash-out): Amiodarone, Etidronate Single-dose, replicate design Highly Variable Drugs Multiple-dose, two-way crossover, fasted Less Sensitive: Clozapine (Patient Trials);

文档评论(0)

1亿VIP精品文档

相关文档